Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$7.35 - $13.21 $1.4 Million - $2.51 Million
-189,900 Reduced 28.7%
471,872 $3.47 Million
Q1 2023

May 15, 2023

BUY
$7.79 - $16.29 $1.35 Million - $2.83 Million
173,891 Added 35.64%
661,772 $6.86 Million
Q4 2022

Feb 14, 2023

BUY
$11.0 - $21.45 $2.15 Million - $4.2 Million
195,604 Added 66.92%
487,881 $5.76 Million
Q3 2022

Nov 14, 2022

SELL
$20.09 - $35.8 $667,610 - $1.19 Million
-33,231 Reduced 10.21%
292,277 $6.14 Million
Q2 2022

Aug 15, 2022

BUY
$27.42 - $43.63 $891,725 - $1.42 Million
32,521 Added 11.1%
325,508 $10.1 Million
Q1 2022

May 16, 2022

BUY
$36.48 - $52.22 $3.72 Million - $5.33 Million
102,046 Added 53.44%
292,987 $12 Million
Q4 2021

Feb 14, 2022

BUY
$33.11 - $55.01 $57,214 - $95,057
1,728 Added 0.91%
190,941 $8.3 Million
Q3 2021

Nov 15, 2021

SELL
$50.07 - $66.05 $391,246 - $516,114
-7,814 Reduced 3.97%
189,213 $9.47 Million
Q2 2021

Aug 16, 2021

BUY
$56.61 - $80.46 $11.2 Million - $15.9 Million
197,027 New
197,027 $12.4 Million
Q4 2020

Feb 16, 2021

SELL
$79.17 - $111.47 $6.95 Million - $9.78 Million
-87,748 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$81.91 - $134.94 $6.8 Million - $11.2 Million
83,036 Added 1762.22%
87,748 $9.07 Million
Q2 2020

Aug 14, 2020

SELL
$54.33 - $89.52 $318,971 - $525,571
-5,871 Reduced 55.48%
4,712 $373,000
Q1 2020

May 15, 2020

BUY
$49.34 - $68.76 $195,139 - $271,945
3,955 Added 59.67%
10,583 $612,000
Q4 2019

Feb 14, 2020

SELL
$51.21 - $59.06 $1.37 Million - $1.58 Million
-26,696 Reduced 80.11%
6,628 $358,000
Q3 2019

Nov 14, 2019

BUY
$40.6 - $57.2 $708,794 - $998,597
17,458 Added 110.03%
33,324 $1.74 Million
Q2 2019

Aug 14, 2019

BUY
$39.92 - $53.86 $633,370 - $854,542
15,866 New
15,866 $766,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.